These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 14961931)

  • 21. Bipolar disorder: from genes to behavior pathways.
    Martinowich K; Schloesser RJ; Manji HK
    J Clin Invest; 2009 Apr; 119(4):726-36. PubMed ID: 19339764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuropathology of bipolar disorder.
    Vawter MP; Freed WJ; Kleinman JE
    Biol Psychiatry; 2000 Sep; 48(6):486-504. PubMed ID: 11018222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroactive steroids are altered in schizophrenia and bipolar disorder: relevance to pathophysiology and therapeutics.
    Marx CE; Stevens RD; Shampine LJ; Uzunova V; Trost WT; Butterfield MI; Massing MW; Hamer RM; Morrow AL; Lieberman JA
    Neuropsychopharmacology; 2006 Jun; 31(6):1249-63. PubMed ID: 16319920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurobiology of bipolar illness: implications for future study and therapeutics.
    Post RM; Speer AM; Hough CJ; Xing G
    Ann Clin Psychiatry; 2003 Jun; 15(2):85-94. PubMed ID: 12938866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The nature of bipolar disorder.
    Manji HK; Lenox RH
    J Clin Psychiatry; 2000; 61 Supp 13():42-57. PubMed ID: 11153812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bipolar disorder and epilepsy: a bidirectional relation? Neurobiological underpinnings, current hypotheses, and future research directions.
    Mazza M; Di Nicola M; Della Marca G; Janiri L; Bria P; Mazza S
    Neuroscientist; 2007 Aug; 13(4):392-404. PubMed ID: 17644769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell pathology in bipolar disorder.
    Rajkowska G
    Bipolar Disord; 2002 Apr; 4(2):105-16. PubMed ID: 12071508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurobiology of bipolar disorder.
    Newberg AR; Catapano LA; Zarate CA; Manji HK
    Expert Rev Neurother; 2008 Jan; 8(1):93-110. PubMed ID: 18088203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toward constructing an endophenotype strategy for bipolar disorders.
    Hasler G; Drevets WC; Gould TD; Gottesman II; Manji HK
    Biol Psychiatry; 2006 Jul; 60(2):93-105. PubMed ID: 16406007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurobiological trait abnormalities in bipolar disorder.
    Langan C; McDonald C
    Mol Psychiatry; 2009 Sep; 14(9):833-46. PubMed ID: 19455151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphometric post-mortem studies in bipolar disorder: possible association with oxidative stress and apoptosis.
    Gigante AD; Young LT; Yatham LN; Andreazza AC; Nery FG; Grinberg LT; Heinsen H; Lafer B
    Int J Neuropsychopharmacol; 2011 Sep; 14(8):1075-89. PubMed ID: 21205433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gray matter abnormalities as brain structural vulnerability factors for bipolar disorder: A review of neuroimaging studies of individuals at high genetic risk for bipolar disorder.
    Nery FG; Monkul ES; Lafer B
    Aust N Z J Psychiatry; 2013 Dec; 47(12):1124-35. PubMed ID: 23864160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of dopamine in bipolar disorder.
    Cousins DA; Butts K; Young AH
    Bipolar Disord; 2009 Dec; 11(8):787-806. PubMed ID: 19922550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of Wnt signaling and its interaction with diverse mechanisms of cellular apoptosis in the pathophysiology of bipolar disorder.
    Hu LW; Kawamoto EM; Brietzke E; Scavone C; Lafer B
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):11-7. PubMed ID: 20828594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder.
    Benes FM; Berretta S
    Neuropsychopharmacology; 2001 Jul; 25(1):1-27. PubMed ID: 11377916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in neuroanatomical sites of apoD elevation discriminate between schizophrenia and bipolar disorder.
    Thomas EA; Dean B; Scarr E; Copolov D; Sutcliffe JG
    Mol Psychiatry; 2003 Feb; 8(2):167-75. PubMed ID: 12610649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced gamma-aminobutyric acid(A)-benzodiazepine binding sites in insular cortex of individuals with panic disorder.
    Cameron OG; Huang GC; Nichols T; Koeppe RA; Minoshima S; Rose D; Frey KA
    Arch Gen Psychiatry; 2007 Jul; 64(7):793-800. PubMed ID: 17606813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of medication on neuroimaging findings in bipolar disorder: an updated review.
    Hafeman DM; Chang KD; Garrett AS; Sanders EM; Phillips ML
    Bipolar Disord; 2012 Jun; 14(4):375-410. PubMed ID: 22631621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of [35S]t-butylbicyclophosphorothionate ([35S]TBPS) binding to GABAA receptors in postmortem human brain.
    Atack JR; Ohashi Y; McKernan RM
    Br J Pharmacol; 2007 Apr; 150(8):1066-74. PubMed ID: 17339834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential regional N-acetylaspartate deficits in postmortem brain in schizophrenia, bipolar disorder and major depressive disorder.
    Reynolds LM; Reynolds GP
    J Psychiatr Res; 2011 Jan; 45(1):54-9. PubMed ID: 20684832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.